Ospedale Ss. Giovanni E Paolo
- Address
- Sestiere Castello 6777, 30122 Venice, Italy
Ospedale Ss. Giovanni E Paolo - Vascular Disease Research Center
Ospedale Ss. Giovanni E Paolo is a distinguished medical research institution specializing in advanced vascular disease management and cardiovascular complications. The center demonstrates particular expertise in studying complex thromboembolic conditions and peripheral vascular disorders, with a focus on developing innovative therapeutic strategies for high-risk patient populations.
- Cancer-associated venous thromboembolism (VTE) and novel anticoagulation therapies
- Peripheral artery disease (PAD) and cardiovascular risk reduction
- Anti-inflammatory interventions for vascular protection
The research center is actively engaged in phase 3 clinical trials evaluating next-generation treatments for venous thromboembolism in cancer patients, comparing novel anticoagulants to standard therapies for preventing VTE recurrence while minimizing bleeding complications. Additionally, the institution investigates the potential of low-dose colchicine therapy in patients with peripheral arterial disease, examining its efficacy in reducing major adverse cardiovascular events including myocardial infarction, stroke, and severe limb ischemia requiring vascular interventions or amputation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ospedale Ss. Giovanni E Paolo
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Low-Dose Colchicine in Reducing Cardiovascular Events in Patients with Peripheral Arterial Disease: A Randomized Controlled Trial | Hamilton Health Sciences Corporation | Phase III | Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abelacimab | 1 | Unknown | 2022-08-10 | 2022-08-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.